Opioid Receptors Influence Ischemia-Reperfusion Injury

Status Suspended

Clinical Trial Summary

The most powerful protective mechanism against ischemia-reperfusion injury other than rapid reperfusion is ischemic preconditioning. Ischemic preconditioning is defined as the development of tolerance to ischemia-reperfusion injury by a previous short bout of ischemia resulting in a marked reduction in infarct size. This mechanism can be mimicked by several pharmacological substances such as adenosine and morphine.

We, the researchers at Radboud University Nijmegen Medical Centre, have recently developed a method in which we can detect ischemia-reperfusion injury in the human forearm by using Annexin A5 scintigraphy (Rongen et al). With this method we will determine whether opioid receptors are involved in ischemic preconditioning. We expect to find that morphine can mimic ischemic preconditioning and that acute ischemic preconditioning can be blocked with the opioid receptor antagonist naloxon. This study will increase our knowledge about the mechanism of ischemic preconditioning and may also provide leads to exploit this endogenous protective mechanism in a clinical setting.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double-Blind

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00184938
Study type	Interventional
Source	Radboud University
Contact
Status	Suspended
Phase	N/A
Start date	January 2005

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05327348` - Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery	Phase 3
Completed	`NCT00184912` - The Effect of Caffeine on Ischemic Preconditioning	N/A
Recruiting	`NCT05585255` - Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury
Completed	`NCT05598177` - Effect of Dexmedetomidine Preconditioning on Myocardial Ischemia-reperfusion Injury in Patients Undergoing Open Heart Surgery With Cardiopulmonary Bypass	Phase 4
Completed	`NCT04284592` - Remote Ischemic Postconditioning Increases HIF-1α Plasma Levels and Improves Cardiac Markers After Cardiac Surgery	N/A
Withdrawn	`NCT00441714` - Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm Exercise	N/A
Completed	`NCT00248040` - Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation	Phase 2
Completed	`NCT01486212` - Ischemia-reperfusion Injury Model on Healthy Volunteers and Measurement of Oxidative and Inflammatory Markers	N/A
Recruiting	`NCT06097702` - A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants	Phase 1
Completed	`NCT00224406` - Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation	Phase 2
Completed	`NCT01073202` - Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation	N/A
Completed	`NCT05246618` - FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation	Phase 1/Phase 2
Completed	`NCT02118753` - The Effect of EPLerenone on Ischemia Reperfusion Injury in Human myoCARDium	N/A
Completed	`NCT01739088` - Pediatric Remote Ischemic Pre-conditioning Prior to Complex Cardiac Surgery	N/A
Completed	`NCT01040013` - Gut Oxygenation and Laparoscopy	Phase 2
Suspended	`NCT00184847` - Adenosine Receptors Influence Ischemia-Reperfusion Injury	N/A
Completed	`NCT01172171` - The Effect of Melatonin on Ischemia-reperfusion Injury Following Acute Myocardial Infarction	Phase 2
Completed	`NCT00457405` - Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?	Phase 4
Completed	`NCT00184821` - Ischemic Injury and Ischemic Preconditioning in Diabetes	N/A
Not yet recruiting	`NCT00691613` - Infusion of a Single Dose of Erythropoietin to Prevent Injury in an Ischemia Reperfusion Forearm Model	N/A